Voloridge Investment Management
DTIL icon

Voloridge Investment Management’s Precision BioSciences DTIL Stock Holding History

Voloridge Investment Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,520
Closed -$2.07M – 1695
2021
Q2 		$2.07M Sell
5,520
-2,426
-31% -$729K 0.01% 982
2021
Q1 		$2.47M Buy
7,946
+5,612
+240% +$1.96M 0.02% 744
2020
Q4 		$584K Buy
+2,334
New +$572K ﹤0.01% 1100
2020
Q2 		– Sell
-582
Closed -$105K – 1310
2020
Q1 		$105K Buy
+582
New +$152K ﹤0.01% 1020

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Voloridge Investment Management's DTIL Position: Q3 2021 in Review

Voloridge Investment Management sold out of Precision BioSciences (DTIL) in Q3 2021, closing a stake of 5,520 shares — an estimated $2.07M sold.

Voloridge Investment Management first reported a position in DTIL in Q1 2020 and held it in 4 quarters. The position peaked at $2.47M in Q1 2021. 132 funds tracked by Wall St. Rank hold DTIL as of Q3 2021.

  • Voloridge Investment Management reported no remaining Precision BioSciences position as of Q3 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 5,520 Precision BioSciences shares in Q3 2021, an estimated $2.07M.
  • Voloridge Investment Management first reported a position in Precision BioSciences in Q1 2020 and held it in 4 quarters.
  • Voloridge Investment Management's Precision BioSciences position peaked at $2.47M in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2021.

Based on Voloridge Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.